[1]
“Complete Histologic Response of Regionally Metastatic Melanoma Treated with Intralesional Interleukin 2, Topical Retinoid and Imiquimod”, J of Skin, vol. 4, no. 6, pp. 575–578, Oct. 2020, doi: 10.25251/skin.4.6.14.